Senate Education Committee Briefing Russell Ingram, Executive
Director March 23, 2011 Slide 2 MRCwhy now? Science and medicine
are at one of those inflection points that you get every so often,
giving rise to very significant opportunities. Professor Sir John
Bell Slide 3 New Science opportunities Computational life science:
advanced computing to solve complex life science problems Genomics:
studies a persons entire DNA sequence Population health: systems
approach to genomic, environmental, and behavioral determinants of
health Regenerative medicine: synthetic tissues and cells,
laboratory-made compounds, and artificial organs Slide 4 The MRC
plan Build on existing New Science Leverage the excellence of
private institutions Develop the strengths of the States
universities Promote productive inter-institutional collaborations
Increase revenue and output Promote aggressive tech transfer and
commercialization Slide 5 The MRC goals Perform great science Grow
annual research spending past $1B $300m increase from current level
Build new blockbuster ventures Educate next generation of
professionals Slide 6 A strong foundation for growth Slide 7
Building on strengths Around $100M new computational science and
genomics investments at St. Jude Existing New Science assets at
UTHSC and UoM Clinical research and genomics at the new, $350M
Lebonheur Childrens Hospital Clinical healthcare and clinical
research The Memphis medical device industry Fedex focus on
biologistics Slide 8 Building on strengths UTHSC Center for
Integrated Translational Genomics Tennessee Mouse Genome
Consortium: experimental genomics resource used worldwide Clinical
translational science programs Molecular Resource Center University
of Memphis School of Public Health Innovative bioinformatics
program Major funded efforts in disease intervention Comprehensive
science resources Joint UM/UTHSC biomedical engineering program
Offers graduate degrees in the fastest growing engineering field in
the country Joint MCAN 10GB fiber optic network Robust VC, startup,
and incubator community Slide 9 Proposed state investment Total FY
2011-2012: $10M $6M: Computational science for genomics and
population health to fight pediatric obesity and diabetes Startup
funds for 5-7 senior, funded scientists Includes needed
infrastructure $4M: Materials science and tissue engineering for
regenerative medicine Startup funds for 2-3 senior, funded
scientists Includes needed infrastructure Slide 10 Use of FY 2011
startup funds Total FY 2010-2011: $500k Slide 11 Repeat TNs
UTK/ORNL success UTK/ORNLs 2002 position is comparable to Memphis
in 2010. With help, Memphis will grow as aggressively as UTK/ORNL.
Slide 12 Expected economic impact Create prosperity 1 5,800 new
jobs 2011-2020 $257 million in new direct wages 2011-2020 $17
billion in new business activity impact 2 Fight pediatric obesity
and diabetes at ground zero Tennessees burden of diabetes in 2006
was $3 billion Memphis burden of diabetes in 2006 was $420 million
Memphis research will design meaningful interventions 1.
Projections based on US Dept of Commerce RIMS II data 2. Business
activity returns over a 10-15 year period. Slide 13 Memphis
research delivers... a source of pride for Tennessee a growing
bioscience workforce a new generation of enterprise new treatments
and cures reduced burden of chronic disease Memphis research is
paying off for Tennessee. Slide 14
